全球高流量氧氣鼻管市場規模、佔有率、趨勢和成長分析報告（2026-2034年）

預計到 2034 年，高流量氧氣鼻管市場規模將達到 20.6 億美元，高於 2025 年的 15.8 億美元，預計從 2026 年到 2034 年的複合年成長率將達到 3.01%。

受呼吸系統疾病日益普遍以及對先進呼吸支持系統需求不斷成長的推動，全球高流量氧氣鼻管市場正穩步成長。高流量氧氣鼻管透過以高流量輸送加溫加濕的氧氣，幫助患者更舒適地呼吸。醫院和醫療機構擴大採用這些設備來治療呼吸衰竭、肺炎和慢性阻塞性肺病（COPD），這進一步促進了全球市場的成長。

推動該市場擴張的因素有很多。特別是，人口老化導致需要呼吸治療的患者數量不斷增加，從而帶動了對高效氧氣療法設備的需求。此外，醫療基礎設施的改善和先進呼吸設備的普及，也加速了醫院對高流量氧氣鼻管系統的採用。提高病患舒適度、氧氣輸送精準度和設備便攜性的技術創新，也促進了市場的發展。

隨著醫療專業人員持續優先考慮非侵入性呼吸支持解決方案，高流量氧氣鼻管市場前景光明。預計對重症監護基礎設施和急救醫療服務投入的增加將促進產品普及。此外，新興市場醫療保健服務的不斷拓展以及呼吸治療技術的持續進步，預計在未來幾年為市場成長創造巨大機會。

目錄

第1章：引言

第2章執行摘要

第3章 市場變數、趨勢與框架

• 市場譜系展望
• 滲透率和成長前景分析
• 價值鏈分析
• 法律規範
  • 標準與合規性
  • 監管影響分析
• 市場動態
  • 市場促進因素
  • 市場限制因素
  • 市場機遇
  • 市場挑戰
• 波特五力分析
• PESTLE分析

第4章：全球高流量氧氣鼻管市場：依組件分類

• 市場分析、洞察與預測
• 空氣/氧氣混合器
• 主動式加濕器
• 氧氣鼻管
• 加熱進氣迴路
• 消耗品

第5章：全球高流量氧氣鼻管市場：依醫療應用分類

• 市場分析、洞察與預測
• 急性呼吸衰竭
• 慢性阻塞性肺病
• 支氣管擴張
• 一氧化碳中毒
• 睡眠呼吸中止症
• 急性心臟衰竭

第6章：全球高流量氧氣鼻管市場：依最終用戶分類

• 市場分析、洞察與預測
• 醫院
• 專科診所
• 長期照護機構
• 門診部
• 居家醫療環境

第7章：全球高流量氧氣鼻管市場：依地區分類

• 區域分析
• 北美市場分析、洞察與預測
  • 美國
  • 加拿大
  • 墨西哥
• 歐洲市場分析、洞察與預測
  • 英國
  • 法國
  • 德國
  • 義大利
  • 俄羅斯
  • 其他歐洲國家
• 亞太市場分析、洞察與預測
  • 印度
  • 日本
  • 韓國
  • 澳洲
  • 東南亞
  • 其他亞太國家
• 拉丁美洲市場分析、洞察與預測
  • 巴西
  • 阿根廷
  • 秘魯
  • 智利
  • 其他拉丁美洲國家
• 中東和非洲市場分析、洞察與預測
  • 沙烏地阿拉伯
  • UAE
  • 以色列
  • 南非
  • 其他中東和非洲國家

第8章 競爭情勢

• 最新趨勢
• 公司分類
• 供應鏈和銷售管道合作夥伴（根據現有資訊）
• 市場佔有率和市場定位分析（基於現有資訊）
• 供應商情況（基於現有資訊）
• 策略規劃

第9章：公司簡介

• 主要公司的市佔率分析
• 公司簡介
  • CR Bard Inc
  • Fisher & Paykel Healthcare Limited
  • Vapotherm Inc
  • Teleflex Incorporated
  • Teijin Pharma Limited
  • TNI Medical AG
  • ResMed Corporation
  • Smiths Medical
  • MEK-ICS Co. Ltd
  • Hamilton Medical AG
  • Flexicare Medical Limited

The High Flow Nasal Cannula Market size is expected to reach USD 2.06 Billion in 2034 from USD 1.58 Billion (2025) growing at a CAGR of 3.01% during 2026-2034.

The global high flow nasal cannula market is growing steadily due to the increasing prevalence of respiratory diseases and the rising demand for advanced respiratory support systems. High flow nasal cannula devices deliver heated and humidified oxygen at high flow rates, helping patients breathe more comfortably. Hospitals and healthcare facilities are increasingly adopting these devices for treating conditions such as respiratory failure, pneumonia, and chronic obstructive pulmonary disease, which is supporting consistent market growth worldwide.

Several factors are driving the expansion of this market. The rising number of patients requiring respiratory care, particularly among aging populations, is increasing the demand for effective oxygen therapy devices. Additionally, improvements in healthcare infrastructure and the growing availability of advanced respiratory equipment are encouraging hospitals to adopt high flow nasal cannula systems. Technological innovations that enhance patient comfort, oxygen delivery accuracy, and device portability are also contributing to the market's development.

The future outlook of the high flow nasal cannula market appears promising as healthcare providers continue to prioritize non-invasive respiratory support solutions. Increasing investments in critical care infrastructure and emergency healthcare services are expected to boost product adoption. Moreover, expanding healthcare access in emerging economies and ongoing advancements in respiratory therapy technologies are likely to create significant opportunities for market growth in the coming years.

Our reports are meticulously crafted to provide clients with comprehensive and actionable insights into various industries and markets. Each report encompasses several critical components to ensure a thorough understanding of the market landscape:

Market Overview: A detailed introduction to the market, including definitions, classifications, and an overview of the industry's current state.

Market Dynamics: In-depth analysis of key drivers, restraints, opportunities, and challenges influencing market growth. This section examines factors such as technological advancements, regulatory changes, and emerging trends.

Segmentation Analysis: Breakdown of the market into distinct segments based on criteria like product type, application, end-user, and geography. This analysis highlights the performance and potential of each segment.

Competitive Landscape: Comprehensive assessment of major market players, including their market share, product portfolio, strategic initiatives, and financial performance. This section provides insights into the competitive dynamics and key strategies adopted by leading companies.

Market Forecast: Projections of market size and growth trends over a specified period, based on historical data and current market conditions. This includes quantitative analyses and graphical representations to illustrate future market trajectories.

Regional Analysis: Evaluation of market performance across different geographical regions, identifying key markets and regional trends. This helps in understanding regional market dynamics and opportunities.

Emerging Trends and Opportunities: Identification of current and emerging market trends, technological innovations, and potential areas for investment. This section offers insights into future market developments and growth prospects.

MARKET SEGMENTATION

By Component

• Air/Oxygen Blenders
• Active Humidifiers
• Nasal Cannulas
• Heated Inspiratory Circuits
• Consumables

By Medical Application

• Acute Respiratory Failure
• Chronic Obstructive Pulmonary Disease
• Bronchiectasis
• Carbon Monoxide Toxicity
• Sleep Apnea
• Acute Heart Failure

By End User

• Hospitals
• Specialty Clinics
• Long Term Care Centers
• Ambulatory Care Centers
• Homecare Settings

COMPANIES PROFILED

• CR Bard Inc, Fisher Paykel Healthcare Limited, Vapotherm Inc, Teleflex Incorporated, Teijin Pharma Limited, TNI Medical AG, ResMed Corporation, Smiths Medical, MEKICS Co Ltd, Hamilton Medical AG, Flexicare Medical Limited
• We can customise the report as per your requirements.

TABLE OF CONTENTS

Chapter 1. PREFACE

• 1.1. Market Segmentation & Scope
• 1.2. Market Definition
• 1.3. Information Procurement
  • 1.3.1 Information Analysis
  • 1.3.2 Market Formulation & Data Visualization
  • 1.3.3 Data Validation & Publishing
• 1.4. Research Scope and Assumptions
  • 1.4.1 List of Data Sources

Chapter 2. EXECUTIVE SUMMARY

• 2.1. Market Snapshot
• 2.2. Segmental Outlook
• 2.3. Competitive Outlook

Chapter 3. MARKET VARIABLES, TRENDS, FRAMEWORK

• 3.1. Market Lineage Outlook
• 3.2. Penetration & Growth Prospect Mapping
• 3.3. Value Chain Analysis
• 3.4. Regulatory Framework
  • 3.4.1 Standards & Compliance
  • 3.4.2 Regulatory Impact Analysis
• 3.5. Market Dynamics
  • 3.5.1 Market Drivers
  • 3.5.2 Market Restraints
  • 3.5.3 Market Opportunities
  • 3.5.4 Market Challenges
• 3.6. Porter's Five Forces Analysis
• 3.7. PESTLE Analysis

Chapter 4. GLOBAL HIGH FLOW NASAL CANNULA MARKET: BY COMPONENT 2022-2034 (USD MN)

• 4.1. Market Analysis, Insights and Forecast Component
• 4.2. Air/Oxygen Blenders Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.3. Active Humidifiers Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.4. Nasal Cannulas Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.5. Heated Inspiratory Circuits Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.6. Consumables Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 5. GLOBAL HIGH FLOW NASAL CANNULA MARKET: BY MEDICAL APPLICATION 2022-2034 (USD MN)

• 5.1. Market Analysis, Insights and Forecast Medical Application
• 5.2. Acute Respiratory Failure Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.3. Chronic Obstructive Pulmonary Disease Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.4. Bronchiectasis Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.5. Carbon Monoxide Toxicity Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.6. Sleep Apnea Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.7. Acute Heart Failure Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 6. GLOBAL HIGH FLOW NASAL CANNULA MARKET: BY END USER 2022-2034 (USD MN)

• 6.1. Market Analysis, Insights and Forecast End User
• 6.2. Hospitals Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.3. Specialty Clinics Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.4. Long Term Care Centers Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.5. Ambulatory Care Centers Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.6. Homecare Settings Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 7. GLOBAL HIGH FLOW NASAL CANNULA MARKET: BY REGION 2022-2034(USD MN)

• 7.1. Regional Outlook
• 7.2. North America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.2.1 By Component
  • 7.2.2 By Medical Application
  • 7.2.3 By End User
  • 7.2.4 United States
  • 7.2.5 Canada
  • 7.2.6 Mexico
• 7.3. Europe Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.3.1 By Component
  • 7.3.2 By Medical Application
  • 7.3.3 By End User
  • 7.3.4 United Kingdom
  • 7.3.5 France
  • 7.3.6 Germany
  • 7.3.7 Italy
  • 7.3.8 Russia
  • 7.3.9 Rest Of Europe
• 7.4. Asia-Pacific Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.4.1 By Component
  • 7.4.2 By Medical Application
  • 7.4.3 By End User
  • 7.4.4 India
  • 7.4.5 Japan
  • 7.4.6 South Korea
  • 7.4.7 Australia
  • 7.4.8 South East Asia
  • 7.4.9 Rest Of Asia Pacific
• 7.5. Latin America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.5.1 By Component
  • 7.5.2 By Medical Application
  • 7.5.3 By End User
  • 7.5.4 Brazil
  • 7.5.5 Argentina
  • 7.5.6 Peru
  • 7.5.7 Chile
  • 7.5.8 South East Asia
  • 7.5.9 Rest of Latin America
• 7.6. Middle East & Africa Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.6.1 By Component
  • 7.6.2 By Medical Application
  • 7.6.3 By End User
  • 7.6.4 Saudi Arabia
  • 7.6.5 UAE
  • 7.6.6 Israel
  • 7.6.7 South Africa
  • 7.6.8 Rest of the Middle East And Africa

Chapter 8. COMPETITIVE LANDSCAPE

• 8.1. Recent Developments
• 8.2. Company Categorization
• 8.3. Supply Chain & Channel Partners (based on availability)
• 8.4. Market Share & Positioning Analysis (based on availability)
• 8.5. Vendor Landscape (based on availability)
• 8.6. Strategy Mapping

Chapter 9. COMPANY PROFILES OF GLOBAL HIGH FLOW NASAL CANNULA INDUSTRY

• 9.1. Top Companies Market Share Analysis
• 9.2. Company Profiles
  • 9.2.1 C.R. Bard Inc
  • 9.2.2 Fisher & Paykel Healthcare Limited
  • 9.2.3 Vapotherm Inc
  • 9.2.4 Teleflex Incorporated
  • 9.2.5 Teijin Pharma Limited
  • 9.2.6 TNI Medical AG
  • 9.2.7 ResMed Corporation
  • 9.2.8 Smiths Medical
  • 9.2.9 MEK-ICS Co. Ltd
  • 9.2.10 Hamilton Medical AG
  • 9.2.11 Flexicare Medical Limited